InflaRx NV (IFRX)
1.72
+0.01
(+0.58%)
USD |
NASDAQ |
Oct 02, 16:00
1.725
0.00 (0.00%)
After-Hours: 20:00
InflaRx EPS Diluted (Quarterly) : -0.1052 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1052 |
| March 31, 2026 | -0.0905 |
| September 30, 2025 | -0.2115 |
| June 30, 2025 | -0.2412 |
| March 31, 2025 | -0.1382 |
| September 30, 2024 | -0.3255 |
| June 30, 2024 | -0.2531 |
| March 31, 2024 | -0.178 |
| December 31, 2023 | -0.2909 |
| September 30, 2023 | -0.1377 |
| June 30, 2023 | -0.1566 |
| March 31, 2023 | -0.2656 |
| December 31, 2022 | -0.1851 |
| September 30, 2022 | -0.1804 |
| June 30, 2022 | 0.0112 |
| March 31, 2022 | -0.3554 |
| December 31, 2021 | -0.3276 |
| September 30, 2021 | -0.3216 |
| June 30, 2021 | -0.4033 |
| March 31, 2021 | -0.2182 |
| December 31, 2020 | -0.3741 |
| September 30, 2020 | -0.2891 |
| Date | Value |
|---|---|
| June 30, 2020 | -0.4222 |
| March 31, 2020 | -0.3475 |
| December 31, 2019 | -0.5787 |
| September 30, 2019 | -0.6205 |
| June 30, 2019 | -0.6609 |
| March 31, 2019 | -0.4302 |
| December 31, 2018 | -0.4516 |
| September 30, 2018 | -0.307 |
| June 30, 2018 | -0.1191 |
| March 31, 2018 | -0.4916 |
| December 31, 2017 | -1.950 |
| September 30, 2017 | -0.6743 |
| June 30, 2017 | -0.728 |
| March 31, 2017 | -0.5732 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | -0.1705 |
| March 31, 2016 | -0.2114 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| MediGene AG | -- |
| BioNTech SE | -3.799 |
| Immatics NV | -0.5316 |
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.38M |
| Total Expenses (Quarterly) | 12.38M |
| Enterprise Value | 73.20M |
| Earnings Yield | -37.70% |
| Normalized Earnings Yield | -33.01 |